近年来,影像组学在各种良恶性肿瘤的非侵入性诊断、治疗方案选择、疗效和预后评估等方面的应用发展迅速,成为最近几年影像医学的发展新方向和研究热点.影像组学是通过将影像特征转化为数据特征,通过大量数据特征探索影像与组织病理、生理的关系,进而达到诊断疾病、预后评估等目的.本文主要阐述影像组学在肝细胞癌(HCC)患者经导管肝动脉化疗栓塞(TACE)治疗中的应用,包括影像组学在TACE术后的疗效预测、筛选不适合TACE治疗的患者、目前影像组学应用于HCC患者TACE治疗的局限性及未来的展望和研究方向等.
In recent years,the application of radiomics in personalized diagnosis,treatment plan selection,efficacy and prognosis evaluation of various benign and malignant tumors has developed rapidly,becoming a new direction and research hotspot in the field of imaging medicine.Imaging omics is the process of transforming image features into data features,exploring the relationship between images and tissue pathology and physiology through a large amount of data features,in order to achieve the goals of disease diagnosis,prognosis evaluation,and so on.This article mainly elaborates on the application of radiomics in the treatment of transcatheter hepatic artery chemoembolization in hepatocellular carcinoma patients,including the prediction of postoperative efficacy of radiomics in TACE,screening of patients who are not suitable for TACE treatment,limitations of current radiomics application in TACE treatment of HCC patients,and future prospects and research directions.
帅师;唐艳隆
大理大学第一附属医院放射科,云南大理,671000
影像组学;肝细胞癌;经导管肝动脉化疗栓塞;预后预测;疗效预测
radiomics;hepatocellular carcinoma;transcatheter arterial chemoembolization;prognostic prediction;efficacy predic-tion
《影像科学与光化学》 2024 (001)
71-76 / 6
云南省科学技术厅地方高校联合专项(202001BA070001-149)
10.7517/issn.1674-0475.230905
评论